CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo
Nicole Mende(Roche (Switzerland)), Claudia Waskow(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI))
Cited by 69
Related Papers
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826
Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia
|eLife|2024|24